Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care

Perla R. Colunga Pedraza, MD, Julia Esther Colunga Pedraza, MD, Andres Gomez-De Leon, MD, Mónica Bustillos Muñoz, MD, Karen Lorena Osorno-Rodriguez, MD, Jose Angel Hawing, MD, Oscar Gonzalez Llano, MD, Yajaira Valentine Jimenez-Antolinez, MD, Olga Graciela Cantu Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-142035

Published: 2020

Journal Articles

Incorporating Reduced-Dose Plerixafor to a Preemptive Mobilization Algorithm Increases Access to Autologous Transplantation in a Limited-Resource Setting

Andrés Gómez-De León, MD, Dalila Marisol Alvarado Navarro, MD, Cesar O Pezina Cantú, MD, Perla R. Colunga Pedraza, MD, David Gomez-Almaguer, MD, Rosario Salazar Riojas, Chem., Olga Graciela Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Jose Carlos Jaime, MD PhD, Cesar Homero Gutierrez-Aguirre, PhD

Blood (2019) 134 (Supplement_1): 4476.

https://doi.org/10.1182/blood-2019-129516

Published: 2019

Journal Articles

Aspicular Bone Marrow Aspiration: A Common, but Not a Minor Problem

Jose Angel Hawing, MD, Olga Graciela Cantu Rodriguez, MD, Andrés Gómez-De León, MD, Consuelo Mancias, MD, Luz del Carmen Tarín Arzaga, MD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 5841.

https://doi.org/10.1182/blood-2019-131662

Published: 2019

Journal Articles

Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation

Cesar Homero Gutierrez-Aguirre, PhD, Olga Graciela Cantu Rodriguez, MD, Fernando De la Garza-Salazar, MD, Rosario Salazar Riojas, Chem., Andres Gomez De Leon, MD, Perla R. Colunga Pedraza, MD, Geraldina Guerrero-González, PhD, Jose Carlos Jaime, MD PhD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, David Gomez-Almaguer, MD, Oscar Gonzalez Llano, MD, Consuelo Mancias, MD

Blood (2019) 134 (Supplement_1): 1967.

https://doi.org/10.1182/blood-2019-131791

Published: 2019

Journal Articles

The Road to Day 0: Identification of Barriers from HLA Typing to Transplantation in the Era of Haploidentical Grafts and Post-Transplant Cyclophosphamide

Perla R. Colunga Pedraza, MD, Andrés Gómez-De León, MD, Mónica Bustillos Muñoz, MD, Diana E Garcia-Camarillo, MD, Rosario Salazar Riojas, Chem., Leslie Silva López, Quem., Olga Graciela Cantu Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 2057.

https://doi.org/10.1182/blood-2019-131627

Published: 2019

Journal Articles

Low Dose Rituximab and Plasma Exchange As Frontline Therapy for Patients with Thrombotic Thrombocytopenic Purpura

Alberto Vazquez Mellado, MD, Olga Graciela Cantu-Rodriguez, MD, Myrna Pequeño-Luévano, MD, Laura Villarreal-Martínez, MD, José Carlos Jaime-Pérez, MD, Andres Gomez-De-Leon, MD, Oscar Gonzalez-Llano, MD PhD, Perla Colunga-Pedraza, MD, Guillermo Sotomayor-Duque, David Gomez-Almaguer, MD

Blood (2015) 126 (23): 2257.

https://doi.org/10.1182/blood.V126.23.2257.2257

Published: 2015

Journal Articles

Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting

Olga Graciela Cantú-Rodríguez, MD, Fernando Lavalle-Gonzalez, MD, Miguel Angel Herrera-Rojas, MD, Cesar H Gutiérrez-Aguirre, MD, Consuelo Mancías-Guerra, MD, Jose Carlos Jaime-Pérez, MD, Oscar Gonzalez-Llano, MD, Alfonso Zapata-Garrido, MD, Jesus Zacarias Villarreal-Perez, MD, David Gomez-Almaguer, MD

Blood (2014) 124 (21): 1191.

https://doi.org/10.1182/blood.V124.21.1191.1191

Published: 2014

Journal Articles

Eltrombopag and High-Dose Dexamethasone As First Line Treatment For ITP

David Gomez-Almaguer, MD, Miguel Angel Herrera-Rojas, MD, Andres Gomez-de Leon, MD, Olga Graciela Cantú-Rodríguez, MD, Cesar H Gutiérrez-Aguirre, MD, Jose Carlos Jaime-Pérez, MD, Luz C. Tarin-Arzaga, MD, Guillermo J. Ruiz-Arguelles, MD, FRCP (Glasg), MACP, Jesus Hernandez-Reyes, MD

Blood (2013) 122 (21): 3544.

https://doi.org/10.1182/blood.V122.21.3544.3544

Published: 2013

Journal Articles

Low-Dose Nilotinib and Imatinib Combination In CML Patients, With Failure, Suboptimal Response Or Treatment Intolerance To First Line Imatinib Treatment. A Pilot Study

David Gomez-Almaguer, MD, Roxana Saldaña-Vázquez, MD, Olga Graciela Cantú-Rodríguez, MD, Cesar H Gutiérrez-Aguirre, MD, Jose Carlos Jaime-Pérez, MD, Luz C. Tarin-Arzaga, MD

Blood (2013) 122 (21): 4034.

https://doi.org/10.1182/blood.V122.21.4034.4034

Published: 2013

NARROW

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care

Incorporating Reduced-Dose Plerixafor to a Preemptive Mobilization Algorithm Increases Access to Autologous Transplantation in a Limited-Resource Setting

Aspicular Bone Marrow Aspiration: A Common, but Not a Minor Problem

Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation

The Road to Day 0: Identification of Barriers from HLA Typing to Transplantation in the Era of Haploidentical Grafts and Post-Transplant Cyclophosphamide

Low Dose Rituximab and Plasma Exchange As Frontline Therapy for Patients with Thrombotic Thrombocytopenic Purpura

Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting

Eltrombopag and High-Dose Dexamethasone As First Line Treatment For ITP

Low-Dose Nilotinib and Imatinib Combination In CML Patients, With Failure, Suboptimal Response Or Treatment Intolerance To First Line Imatinib Treatment. A Pilot Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only